News + Filings Transactions
|
TANEN DAVID M
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/22/2022 | Kronos Bio, Inc. | KRON | Grant | Stock Option (Right to Buy) | 34k | $3.53 | $120k | | 06/22/2022 |
| 06/22/2021 | Kronos Bio, Inc. | KRON | Grant | Stock Option (Right to Buy) | 20.6k | $24.18 | $498.1k | | 06/22/2021 |
| 10/14/2020 | Kronos Bio, Inc. | KRON | Conversion | Series Seed Preferred Stock | 221.2k | $0.00 | $0 | See footnote | 10/14/2020 |
| 10/14/2020 | Kronos Bio, Inc. | KRON | Conversion | Convertible Promissory Note | 0 | $16.15 | $0 | See footnote | 10/14/2020 |
| 10/14/2020 | Kronos Bio, Inc. | KRON | Conversion | Series A Preferred Stock | 65.2k | $0.00 | $0 | See footnote | 10/14/2020 |
| 10/14/2020 | Kronos Bio, Inc. | KRON | Conversion | Series Seed Preferred Stock | 219.5k | $0.00 | $0 | | 10/14/2020 |
| 10/14/2020 | Kronos Bio, Inc. | KRON | Conversion | Common Stock | 37.1k | $16.15 | $599.5k | See footnote | 10/14/2020 |
| 10/14/2020 | Kronos Bio, Inc. | KRON | Conversion | Common Stock | 68.8k | $0.00 | $0 | See footnote | 10/14/2020 |
| 10/14/2020 | Kronos Bio, Inc. | KRON | Conversion | Common Stock | 233.4k | $0.00 | $0 | See footnote | 10/14/2020 |
| 10/14/2020 | Kronos Bio, Inc. | KRON | Conversion | Common Stock | 231.6k | $0.00 | $0 | | 10/14/2020 |
| 10/03/2016 | Arno Therapeutics, Inc | ARNI | Purchase | 2016 Series F Warrants (right to buy) | 71.4k | $0.44 | $31.2k | | 10/03/2016 |
| 10/03/2016 | Arno Therapeutics, Inc | ARNI | Purchase | Common Stock | 142.9k | $0.00 | $0 | | 10/03/2016 |
| 04/07/2016 | Arno Therapeutics, Inc | ARNI | Grant | Stock Option (right to buy) | 88.6k | $0.37 | $32.8k | | 04/07/2016 |
| 01/12/2016 | Arno Therapeutics, Inc | ARNI | Purchase | Common Stock | 362k | $0.35 | $126.7k | By Trust | 01/12/2016 |
| 01/24/2014 | Arno Therapeutics, Inc | ARNI | Grant | Stock Option (right to buy) | 34.2k | $2.90 | $99.2k | | 01/24/2014 |
| 11/04/2013 | Arno Therapeutics, Inc | ARNI | Grant | Stock Option (right to buy) | 68.4k | $2.40 | $164.3k | | 11/04/2013 |
|